CHICAGO (April 1, 2019) – Rosacea can be a vicious cycle. The more you worry about its dreaded appearance, the likelier the stress may cause it to come crashing in at the worst possible time, showing up in the most conspicuous and embarrassing place—the face—as a redness that won’t go away, often with unsightly bumps and pimples. Fortunately today, rosacea sufferers have more reason than ever to be optimistic.

BARRINGTON, Illinois (February 11, 2019) – Although a cure for rosacea has yet to be discovered, advances in medical therapy have made it increasingly possible for those who suffer from this chronic disorder to achieve clear skin. At the same time, recent surveys have shown just how important this attainable goal is to patients’ physical and mental well-being.

BARRINGTON, Illinois (December 6, 2018) — The National Rosacea Society (NRS) announced today that new grants are available in 2019 to support research into potential causes and other key aspects of rosacea that may lead to improvements in its management, prevention or potential cure.

BARRINGTON, Illinois (July 11, 2018) — How many people in the world have rosacea? Researchers have attempted for the first time to determine the global prevalence of this widespread facial skin disorder, and the answer is estimated to be 415 million.

CHICAGO (April 2, 2018) – Facial redness that doesn’t go away? Inexplicable bumps and pimples? Irritated eyes? All are signs of rosacea, a potentially serious disorder that can now be diagnosed with more precision than ever before. April has been designated as Rosacea Awareness Month to educate the public on this often life-disruptive condition now affecting more than 16 million Americans – and most of them don’t know it.

BARRINGTON, Illinois (February 1, 2018) – When the National Rosacea Society (NRS) published the first standard classification of rosacea 15 years ago, it ushered in an unprecedented era of research into the disease process of this widespread chronic disorder of the facial skin – and now the first update has been published based on these dramatic advances in scientific knowledge.¹ The NRS has designated April as Rosacea Awareness Month to educate the public on the current understanding of this often life-disruptive condition estimated to affect more than 16 millio

Click image for high-resolution version

Click image for high-resolution version

BARRINGTON, Illinois (November 8, 2017) – The National Rosacea Society (NRS) announced today that a new standard classification and pathophysiology of rosacea has been published in the Journal of the American Academy of Dermatology.¹ Developed by a consensus committee and review panel of 28 rosacea experts worldwide, the updated system is based on the substantial advances in the understanding of rosacea gained through scientific investigations over the last 15 years.

BARRINGTON, Illinois (October 16, 2017) — The National Rosacea Society (NRS) announced it has awarded funding for three new studies, in addition to continuing support for three ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvements in its management, prevention or potential cure.

BARRINGTON, Illinois (August 10, 2017) — In a new study funded by the National Rosacea Society (NRS), medical scientists have connected the dots in the disease process of inflammation in rosacea, identifying a potential pathway for significant advances in the treatment of this widespread disorder affecting more than 16 million Americans.

BARRINGTON, Illinois (July 11, 2017) -- What might often be mistaken for a persistent sunburn may actually be rosacea, a widespread facial skin disorder now estimated by the National Rosacea Society (NRS) to affect more than 16 million Americans. Unfortunately, without medical treatment it often grows increasingly more severe and intrusive on daily life.

CHICAGO (April 3, 2017) -- Is your face trying to tell you something? Although new medical research has discovered the red-faced appearance of rosacea may serve as a potential signal for serious but less visible illnesses, only a small fraction of those suffering from this widespread, often embarrassing disorder are currently being treated.

BARRINGTON, Illinois (February 2, 2017) – While new research has tied rosacea to increased risk of a growing number of potentially serious illnesses – including cardiovascular disease, gastrointestinal disease, certain types of cancer and more – only a small fraction of the estimated 16 million Americans suffering from this chronic inflammatory skin disorder are currently receiving medical treatment.

BARRINGTON, Illinois (Sept. 20, 2016) -- The National Rosacea Society (NRS) announced it has awarded funding for three new studies, in addition to continuing support for two ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvements in its management, prevention or potential cure.

BARRINGTON, Illinois (April 1, 2016) -- Could a widespread facial skin disorder be a signal for other possible health problems? New studies are now revealing potential associations between rosacea and increased risks of cardiovascular disease, gastrointestinal disease, certain types of cancer and many other systemic illnesses. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to alert the public to the early warning signs of this chronic and conspicuous facial disorder now estimated to affect more than 16 million Americans.

BARRINGTON, Illinois (February 4, 2016) – While it is well established that individuals with rosacea often face significant physical, emotional and social challenges, new studies are now showing this widespread disorder may also be associated with increased risks of cardiovascular disease, gastrointestinal disease, certain types of cancer and many other systemic illnesses.

ATLANTA (December 17, 2015) -- Medical scientists reviewed research on the microbiome, genetics and pathophysiology of rosacea and presented results of new studies funded by the National Rosacea Society (NRS) during its research workshop at the Society for Investigative Dermatology annual meeting here.

BARRINGTON, Illinois (September 29, 2015) – The National Rosacea Society (NRS) announced it has awarded funding for three new studies, in addition to continuing support for two ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.

SAN FRANCISCO (July 30, 2015) – As research continues to reveal the many ways the human microbiome may affect human health, the potential role of Demodex mites in rosacea has come into sharper focus with new technology and may point to new approaches in patient care, according to experts at a roundtable on the clinical implications of Demodex in rosacea during the recent annual meeting of the American Academy of Dermatology.